ロード中...
Combination Therapy: Histone Deacetylase Inhibitors and Platinum-based Chemotherapeutics for Cancer
One of the most promising strategies to increase the efficacy of standard chemotherapy drugs is by combining them with low doses of histone deacetylases inhibitors (HDACis). Regarded as chemosensitizers, the addition of well-tolerated doses of HDACis to platinum-based chemotherapeutics has been prov...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3546543/ https://ncbi.nlm.nih.gov/pubmed/23032720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2012.09.018 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|